๐ฌIn plain words
What the trial is, and whether it could suit you
This study aims to investigate the effects of 24-hour acute sleep deprivation on plasma Alzheimer's disease biomarkers and multi-omics in individuals with different APOE genotypes, to elucidate the potential role of acute sleep deprivation in AD risk.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion Criteria:
* Age 18-40 years, gender not limited
* Healthy (with no clinically significant abnormal findings in the physical examination report or self-reporting as healthy) and not on medications
* Cognitively normal (Mini-Mental State Examination (MMSE) score \> 28)
* Sleep duration of 7-9 hours per night, good sleep quality (Pittsburgh Sleep Quality Index (PSQI) โค 5 points)
* Written informed consent, voluntarily participate in this study, and be able to cooperate with the physician to complete the clinical study
Exclusion Criteria:
* Presence of day-night sleep reversal
* Shift work within the past 6 months
* Travel across time zones or experience of jet lag within the past three weeks
* Current smoking or nicotine use; alcohol consumption exceeding five standard units per week (one standard alcohol unit is defined as 10 mL \[or 8 g\] of pure alcohol)
* Consumption of strong tea, coffee, or caffeine-containing foods and beverages within one week before study participation
* Family history of early-onset dementia
* Self-Rating Depression Scale (SDS) score โฅ 53, Self-Rating Anxiety Scale (SAS) score โฅ 50
* Female participants who are currently pregnant or breastfeeding
* Individuals who need to drive or operate vehicles or machinery during the study period
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, China
๐ค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ always decide together with your own doctor.